In-Depth: Cirdan – Moving Pathologists From Analyse to Visualise

Dr Hugh Cormican from Cirdan Labs joins Kehlan to talk about their company and their recent investment of £3.5m.

Hugh talks about how the company developed and how they plan to revolutionise pathology, organ and tissue examination, in labs around the world.

They recently received £3.5m in Kernal Capital Seed funding, but that that doesn’t mean huge growth in a short space of time. Hugh explains why this a slow burn and how VC investors understood that from the outset.